Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitriy N Feldman

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
American Heart Journal|September 26, 2007
Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stentsDmitriy N Feldman, S Chiu Wong, Christopher L Gade, et al.
The American Journal of Cardiology|June 4, 2014
Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarctionRamez Nairooz, Partha Sardar, Hossam Amin, et al.
JAMA Network Open|September 28, 2019
Assessment of Hospital Readmission Rates, Risk Factors, and Causes After Cardiac Arrest: Analysis of the US Nationwide Readmissions DatabaseIlhwan Yeo, Jim W Cheung, Dmitriy N Feldman, et al.
The American Journal of Cardiology|December 1, 2006
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)Dmitriy N Feldman, Christopher L Gade, Alexander J Slotwiner, et al.
Journal of Interventional Cardiology|November 29, 2007
Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft diseaseRobert M Minutello, Sherrita Bhagan, Atul Sharma, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 12, 2016
Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011Luke K Kim, Patrick Looser, Rajesh V Swaminathan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 30, 2018
Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysisAmartya Kundu, Partha Sardar, Nikolaos Kakouros, et al.
International Journal of Cardiology|October 6, 2015
Impact of intraprocedural thrombotic events on short- and long-term outcomes following percutaneous coronary intervention. Evidence from a meta-analysisRamez Nairooz, Dmitriy N Feldman, Yogita Rochlani, et al.
International Journal of Cardiology|May 28, 2013
A strategy of 'treating through' a prasugrel-induced rashDavid C Yang, Dmitriy N Feldman, Luke K Kim, et al.
International Journal of Cardiology|June 12, 2018
Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohortParag Goyal, Zaid I Almarzooq, Jim Cheung, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
American Heart Journal|September 26, 2007
Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stentsDmitriy N Feldman, S Chiu Wong, Christopher L Gade, et al.
The American Journal of Cardiology|June 4, 2014
Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarctionRamez Nairooz, Partha Sardar, Hossam Amin, et al.
JAMA Network Open|September 28, 2019
Assessment of Hospital Readmission Rates, Risk Factors, and Causes After Cardiac Arrest: Analysis of the US Nationwide Readmissions DatabaseIlhwan Yeo, Jim W Cheung, Dmitriy N Feldman, et al.
The American Journal of Cardiology|December 1, 2006
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)Dmitriy N Feldman, Christopher L Gade, Alexander J Slotwiner, et al.
Journal of Interventional Cardiology|November 29, 2007
Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft diseaseRobert M Minutello, Sherrita Bhagan, Atul Sharma, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 12, 2016
Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011Luke K Kim, Patrick Looser, Rajesh V Swaminathan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 30, 2018
Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysisAmartya Kundu, Partha Sardar, Nikolaos Kakouros, et al.
International Journal of Cardiology|October 6, 2015
Impact of intraprocedural thrombotic events on short- and long-term outcomes following percutaneous coronary intervention. Evidence from a meta-analysisRamez Nairooz, Dmitriy N Feldman, Yogita Rochlani, et al.
International Journal of Cardiology|May 28, 2013
A strategy of 'treating through' a prasugrel-induced rashDavid C Yang, Dmitriy N Feldman, Luke K Kim, et al.
International Journal of Cardiology|June 12, 2018
Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohortParag Goyal, Zaid I Almarzooq, Jim Cheung, et al.
Pageof 19